Marcopolis.net Video Interview with Ibrahim Diawara, President and CEO of Cipharm, also available here http://marcopolis.net/cipharm-cote-divoire-plans-and-investment-opportunities-0309.htm

"We are open to offers from investors. Obviously, we discuss things with Cauris. You know that in this business there are some very big players and the standards change very quickly. This means that in this industry we are always looking for investment. We constantly need both expertise and financial investment. Therefore, yes we are open to investors. We don´t follow any kind of nationalistic protectionism in this sense. We work will all those who can offer us better know-how and finances to advance in this industry. It would be good to be able to manufacture at least 40% or 50% of our pharmaceutics; that would be for the good of Côte d'Ivoire", says Ibrahim Diawara.

To read the full transcript of the MarcoPolis interview with Ibrahim Diawara, President and CEO of Cipharm, visit Marcopolis.net http://marcopolis.net/cipharm-overview-of-the-pharmaceutical-industry-in-cote-divoire-0209.htm